Nuvation Bio (NUVB) Competitors $4.85 +0.46 (+10.48%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$4.86 +0.01 (+0.10%) As of 10/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB vs. ARWR, ACLX, AKRO, CRNX, MENS, NAMS, KYMR, SRRK, VKTX, and MIRMShould you be buying Nuvation Bio stock or one of its competitors? The main competitors of Nuvation Bio include Arrowhead Pharmaceuticals (ARWR), Arcellx (ACLX), Akero Therapeutics (AKRO), Crinetics Pharmaceuticals (CRNX), Jyong Biotech (MENS), NewAmsterdam Pharma (NAMS), Kymera Therapeutics (KYMR), Scholar Rock (SRRK), Viking Therapeutics (VKTX), and Mirum Pharmaceuticals (MIRM). These companies are all part of the "pharmaceutical products" industry. Nuvation Bio vs. Its Competitors Arrowhead Pharmaceuticals Arcellx Akero Therapeutics Crinetics Pharmaceuticals Jyong Biotech NewAmsterdam Pharma Kymera Therapeutics Scholar Rock Viking Therapeutics Mirum Pharmaceuticals Nuvation Bio (NYSE:NUVB) and Arrowhead Pharmaceuticals (NASDAQ:ARWR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk. Do analysts prefer NUVB or ARWR? Nuvation Bio presently has a consensus price target of $7.86, suggesting a potential upside of 62.00%. Arrowhead Pharmaceuticals has a consensus price target of $43.14, suggesting a potential upside of 13.53%. Given Nuvation Bio's stronger consensus rating and higher probable upside, analysts plainly believe Nuvation Bio is more favorable than Arrowhead Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuvation Bio 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.88Arrowhead Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.78 Is NUVB or ARWR more profitable? Arrowhead Pharmaceuticals has a net margin of 0.00% compared to Nuvation Bio's net margin of -1,413.43%. Arrowhead Pharmaceuticals' return on equity of -40.91% beat Nuvation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Nuvation Bio-1,413.43% -46.14% -36.04% Arrowhead Pharmaceuticals N/A -40.91%-11.62% Do institutionals and insiders hold more shares of NUVB or ARWR? 61.7% of Nuvation Bio shares are held by institutional investors. Comparatively, 62.6% of Arrowhead Pharmaceuticals shares are held by institutional investors. 29.9% of Nuvation Bio shares are held by insiders. Comparatively, 4.3% of Arrowhead Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better valuation and earnings, NUVB or ARWR? Nuvation Bio has higher revenue and earnings than Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals is trading at a lower price-to-earnings ratio than Nuvation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuvation Bio$7.87M210.93-$567.94M-$0.63-7.70Arrowhead Pharmaceuticals$3.55M1,479.97-$599.49M-$1.28-29.69 Which has more risk and volatility, NUVB or ARWR? Nuvation Bio has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Comparatively, Arrowhead Pharmaceuticals has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Does the media prefer NUVB or ARWR? In the previous week, Arrowhead Pharmaceuticals had 3 more articles in the media than Nuvation Bio. MarketBeat recorded 8 mentions for Arrowhead Pharmaceuticals and 5 mentions for Nuvation Bio. Arrowhead Pharmaceuticals' average media sentiment score of 1.05 beat Nuvation Bio's score of 0.02 indicating that Arrowhead Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nuvation Bio 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Arrowhead Pharmaceuticals 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNuvation Bio beats Arrowhead Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUVB vs. The Competition Export to ExcelMetricNuvation BioMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.50B$3.43B$6.24B$22.01BDividend YieldN/A2.27%5.71%3.57%P/E Ratio-7.7025.3030.4633.26Price / Sales210.93510.44595.1393.10Price / CashN/A45.5737.0124.54Price / Book3.5410.4012.044.66Net Income-$567.94M-$52.62M$3.32B$1.01B7 Day Performance42.23%2.09%1.88%2.19%1 Month Performance61.40%12.32%7.68%2.04%1 Year Performance121.46%14.12%56.01%13.99% Nuvation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUVBNuvation Bio2.3298 of 5 stars$4.85+10.5%$7.86+62.0%+111.3%$1.50B$7.87M-7.7060ARWRArrowhead Pharmaceuticals3.6891 of 5 stars$36.25+2.4%$43.14+19.0%+90.7%$4.90B$3.55M-28.32400Positive NewsAnalyst ForecastAnalyst RevisionACLXArcellx2.6617 of 5 stars$86.23-0.7%$112.69+30.7%-2.1%$4.81B$107.94M-25.2180News CoveragePositive NewsAnalyst ForecastAKROAkero Therapeutics3.8122 of 5 stars$53.66-0.4%$73.38+36.7%+87.0%$4.31BN/A-26.8330Positive NewsAnalyst ForecastCRNXCrinetics Pharmaceuticals4.2043 of 5 stars$44.43-1.1%$74.45+67.6%-30.2%$4.23B$1.04M-10.81210Analyst ForecastMENSJyong BiotechN/A$55.70+0.8%N/AN/A$4.20BN/A0.0031NAMSNewAmsterdam Pharma3.4093 of 5 stars$37.15+0.3%$42.00+13.1%+89.4%$4.17B$45.56M-22.934Analyst RevisionHigh Trading VolumeKYMRKymera Therapeutics1.385 of 5 stars$59.89+4.7%$61.26+2.3%+20.2%$4.09B$47.07M-17.26170News CoverageUpcoming EarningsAnalyst ForecastGap UpSRRKScholar Rock4.4686 of 5 stars$34.28-13.1%$47.00+37.1%+2.3%$3.79B$33.19M-11.78140High Trading VolumeVKTXViking Therapeutics4.0427 of 5 stars$33.91+1.0%$86.42+154.8%-53.0%$3.77BN/A-22.1620Trending NewsEarnings ReportAnalyst DowngradeAnalyst RevisionGap UpMIRMMirum Pharmaceuticals3.7498 of 5 stars$72.17-0.7%$76.50+6.0%+77.9%$3.65B$336.89M-59.64140 Related Companies and Tools Related Companies Arrowhead Pharmaceuticals Alternatives Arcellx Alternatives Akero Therapeutics Alternatives Crinetics Pharmaceuticals Alternatives Jyong Biotech Alternatives NewAmsterdam Pharma Alternatives Kymera Therapeutics Alternatives Scholar Rock Alternatives Viking Therapeutics Alternatives Mirum Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUVB) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
